Bridgewater Bancshares Inc. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Bridgewater Bancshares, Inc. (BWB) on June 19, 2020. The filing discloses the entry into a material definitive agreement and the creation of a direct financial obligation through the issuance of subordinated notes.
Key Financial Metrics and Transaction Details
- Transaction Amount: $50.0 million aggregate principal amount.
- Instrument: 5.25% Fixed-to-Floating Rate Subordinated Notes due 2030.
- Interest Rate: Fixed at 5.25% per year from June 19, 2020, to July 1, 2025. Thereafter, the rate resets quarterly to three-month SOFR plus 513 basis points.
- Maturity: July 1, 2030.
- Redemption: Redeemable in whole or in part on or after July 1, 2025, or upon certain events prior to that date.
- Use of Proceeds: General corporate purposes, supporting regulatory capital ratios, and investing in subsidiary Bridgewater Bank.
- Capital Classification: Intended to qualify as Tier 2 capital for regulatory purposes.
Material Changes and Obligations
The Company entered into a Subordinated Note Purchase Agreement and a Registration Rights Agreement with institutional accredited investors. The Notes are unsecured, subordinated obligations ranking junior to senior indebtedness. Under the Registration Rights Agreement, the Company agreed to facilitate an Exchange Offer to provide registered notes with substantially the same terms. Failure to meet obligations under this agreement may trigger additional interest payments to holders.
Outlook, Risks, and Contingencies
The filing includes forward-looking statements regarding the use of proceeds and the Exchange Offer, which are subject to risks and uncertainties. The Notes are not guaranteed by any subsidiary. Principal and interest are subject to acceleration only in limited bankruptcy or insolvency events. The Company does not undertake an obligation to update forward-looking statements.
Investor Verification Checklist
- Verify the impact of the $50.0 million issuance on the Company's regulatory capital ratios.
- Review the full text of the Indenture (Exhibit 4.1) for specific redemption limitations prior to July 1, 2025.
- Confirm the terms of the Registration Rights Agreement (Exhibit 10.2) regarding potential additional interest penalties.
- Assess the Company's liquidity position post-issuance and the specific allocation of proceeds to Bridgewater Bank.